Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, has been selected to provide its RENASYS TOUCH Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year* ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the review of medical technologies guidance from the UK National Institute for Health and Care Excellence (NICE) ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, is pleased to announce the launch of its RENASYS EDGE Negative Pressure Wound Therapy (NPWT) System in the US as a ...
(MENAFN- GlobeNewsWire - Nasdaq) Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an industry-leading portfolio set ...
(RTTNews) - Medical technology company Smith+Nephew (SN.L, SNN) has been selected to provide its Renasys Touch Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year contract for ...
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an industry-leading portfolio set to showcase at the upcoming ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results